- Home
- KROS vs BXC Comparison
KROS vs BXC Comparison
Compare KROS & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | BXC |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | 1700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 587.2M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | KROS | BXC |
|---|---|---|
| Price | $11.02 | $49.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $22.25 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 376.7K | 70.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ 2.30 | 0.02 |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | $4.50 |
| Revenue Next Year | N/A | $6.87 |
| P/E Ratio | ★ $4.78 | $2,536.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.12 | $50.40 |
| 52 Week High | $22.55 | $88.30 |
Technical Indicators
Market Signals| Indicator | KROS | BXC |
|---|---|---|
| Relative Strength Index (RSI) | 17.12 | 19.36 |
| Support Level | N/A | N/A |
| Resistance Level | $15.21 | $73.58 |
| Average True Range (ATR) | 0.71 | 3.53 |
| MACD | -0.22 | -1.83 |
| Stochastic Oscillator | 7.37 | 1.15 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.